AQST

AQUESTIVE THERAPEUTICS INC

Healthcare | Small Cap

-$0.15

EPS Forecast

$10.67

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.15

Revenue Forecast:

$10.67

EPS Surprise Forecast:

-$0.007

Revenue Surprise Forecast:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±9.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

45%

Probability of beating revenue consensus:

47%

Probability of beating both EPS & revs consensus:

28%

Probability of missing both EPS & revs consensus:

36%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.86

Earnings volatility

EPS standard deviation:

$0.10

Revenue standard deviation:

$4

As % of share price:

2.40% VERY HIGH

As % of market cap:

0.72% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.03

Revenue 95th %ile:

$15

EPS 75th %ile:

-$0.11

Revenue 75th %ile:

$12

EPS 25th %ile:

-$0.18

Revenue 25th %ile:

$10

EPS 5th %ile:

-$0.26

Revenue 5th %ile:

$7

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

41% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$20

Bid-ask per Share:

$0.01